Glucose homeostasis may shape Blastocystis spp. abundance in the gut rather than the reverse, with metformin increasing Blastocystis in recently diagnosed type 2 diabetes patients, and Blastocystis being among the microbial genera most strongly associated with telomere length.
Key Findings
Results
Blastocystis spp. and subtypes ST1 and ST4 were associated with glucose and insulin levels across all four independent cohorts.
Four independent cohorts were analyzed: CGM (n=65), IMAGEOMICS (n=1030), PECT (n=841), and MEIFLO (n=22)
Shotgun metagenomic profiles of gut microbiota from fecal samples were used
Both Blastocystis spp. at the genus level and specific subtypes ST1 and ST4 showed associations with glucose metabolism parameters
Microbiome compositional analysis methodology was applied across all cohorts
Results
Metformin treatment (but not placebo) increased Blastocystis spp. abundance in recently diagnosed type 2 diabetes patients.
Data came from MEIFLO, a clinical trial in patients recently diagnosed with type 2 diabetes (n=22)
Linear Models for Differential Abundance were used to investigate metformin-induced changes in gut microbiota
The placebo arm did not show a corresponding increase in Blastocystis spp.
This finding supports the interpretation that glucose homeostasis shapes Blastocystis abundance rather than the reverse
Results
Blastocystis was identified as one of the microbial genera most strongly and directly associated with leukocyte telomere length in the IMAGEOMICS cohort.
The association was identified in the IMAGEOMICS cohort (n=1030)
The relationship between Blastocystis and telomere length was described as direct (positive association)
This finding aligns with observed inverse associations between glucose levels and telomere length
The triangular relationship — glucose inversely associated with telomere length, glucose inversely associated with Blastocystis, and Blastocystis directly associated with telomere length — forms a coherent pattern
Discussion
The study proposes that Blastocystis spp. presence reflects healthy glucose metabolism as an outcome rather than being a causative factor.
Prior literature had suggested Blastocystis might be epiphenomenal to a healthy lifestyle
The clinical trial evidence showing metformin-driven increases in Blastocystis supports a directionality from metabolic health to Blastocystis abundance
The authors propose Blastocystis 'may be associated with healthy glucose metabolism as an outcome and potentially serve as an indicator of improved metabolic health'
Some subtypes were noted in the literature to have beneficial impacts while others may hinder host health
Results
Inverse associations were observed between glucose levels and Blastocystis spp. abundance.
Higher glucose levels were associated with lower Blastocystis spp. abundance
Insulin levels were also associated with Blastocystis spp. presence
These associations were consistent across multiple independent cohorts of varying sizes
Both fasting glucose and insulin parameters were examined as glucose metabolism indicators
What This Means
This research suggests that a gut parasite called Blastocystis — which has been increasingly recognized as potentially beneficial rather than harmful — is linked to better blood sugar regulation. Using data from over 1,900 people across four separate study groups, the researchers found that people with better glucose and insulin levels tended to have more Blastocystis in their gut, while people with higher blood sugar levels had less of it. Specific strains (subtypes ST1 and ST4) showed particularly consistent associations with these metabolic measures.
A key insight came from a small clinical trial in people newly diagnosed with type 2 diabetes. When patients were treated with metformin (a common diabetes medication that improves blood sugar control), their Blastocystis levels increased — but this did not happen in patients who received a placebo. This suggests the direction of influence runs from metabolic health to Blastocystis abundance, rather than Blastocystis causing better metabolism. In other words, improving blood sugar control appears to create gut conditions more favorable to Blastocystis, not the other way around.
The researchers also found that Blastocystis was one of the gut microbes most strongly associated with telomere length — a biological marker often linked to cellular aging and overall health — with more Blastocystis corresponding to longer telomeres. Since higher blood sugar is also associated with shorter telomeres, all three factors (blood sugar, Blastocystis, and telomere length) form a coherent pattern. This research suggests Blastocystis may serve as a useful indicator of metabolic health rather than a driver of it, and raises questions about what gut conditions support or suppress its presence.
Paulí S, Rosell-Díaz M, Moreno-Navarrete J, Pons Tamarit J, Pérez-Brocal V, Moya A, et al.. (2026). Glucose metabolism's impact on Blastocystis presence in the human gut.. Clinical nutrition (Edinburgh, Scotland). https://doi.org/10.1016/j.clnu.2026.106647